LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
Sjoukje F. Oosting, Astrid A.M. van der Veldt, Corine H. GeurtsvanKessel, Rudolf S.N. Fehrmann, Rob van Binnendijk, Anne‐Marie C. Dingemans, Egbert F. Smit, T. Jeroen N. Hiltermann, Gerco den Hartog, Mathilde Jalving, Theresa Westphal, Animesh Battacharya, Marieke van der Heiden, Christian U. Blank, Marion Koopmans, Cornelis Van, Nynke Y. Rots, Debbie van Baarle, John B.A.G. Haanen, Elisabeth G.E. de Vries
Topics & Concepts
MedicineVaccinationImmunotherapyClinical endpointImmunogenicityInternal medicineAdverse effectChemotherapyAntibodyImmunologyCancerClinical trialSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsCancer Immunotherapy and Biomarkers